期刊文献+

肥胖相关肾病 被引量:5

原文传递
导出
摘要 近20年来全球范围肥胖人群成倍增加,在我国随着生活方式及饮食结构的改变,超重和肥胖人群也迅猛增长,并日渐成为突出的社会公共卫生问题。1997年世界卫生组织(WHO)明确宣布肥胖为一种疾病。目前世界各国均将体重指数(body mass index,BMI)、即体重(kg)/身高^2(m^2)比值作为诊断肥胖的指标,不过现有不同的“超重”或“肥胖”判断标准。WHO主要依据西方国家人群数据,BMI25.0~29.9为超重,≥30为肥胖。2002年中国肥胖问题工作组依据我国人群调查数据提出了我国的诊断标准,BMI24.0-27.9为超重,≥28为肥胖。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2007年第4期267-270,共4页 Chinese Journal of Nephrology
  • 相关文献

参考文献21

  • 1Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser,2000, 894: i-xii, 1-253.
  • 2中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(1):5-10. 被引量:3305
  • 3Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med, 1974, 81:440-447.
  • 4Ross WR, McGill JB. Epidemiology of obesity and chronic kidney disease. Adv Chronic Kidney Dis, 2006, 13:325-335.
  • 5de Jong PE, Verhave JC, Pinto-Sietsma SJ, et al. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord, 2002, 26 Suppl g:S21-S2A.
  • 6Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int,2001, 59:1498-1509.
  • 7Adelman RD. Obesity and renal disease. Curr Opin Nephrol Hypertens, 2002, 11:331-335.
  • 8Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol, 2000, 278:F817-F822.
  • 9Praga M, Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens, 2006, 15:481-486.
  • 10Henegar JR, Bigler SA, Henegar LK, et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol, 2001, 12:1211-1217.

二级参考文献25

  • 1张红叶,杨军,周北凡,武阳丰,李莹,陶寿淇.我国十组人群脑卒中危险因素的前瞻性研究[J].中国慢性病预防与控制,1996,4(4):150-152. 被引量:91
  • 2曹家琪 连志浩 等.队列(群组)研究.流行病学,第2版,第1卷[M].北京:人民卫生出版社,1995.190-206.
  • 3Adelman RD, Restaino IG, Alon US et al.Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr, 2001, 138:481
  • 4Praga M, Borstein B, Andres A et al. Nephrotic proteinuria without hypoalbuminemia: Clinical characteristics and response to angiotensin-eonverting enzyme inhibition. Am J Kidney Dis , 1991,17:330
  • 5Praga MP, Morales E, Herrero JC et al. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secnndary to hyperfiltration. Am J Kidney Dis, 1999,33: 52
  • 6Fanstinella F, Uzoh C, sheikh-Hamad D. Glomerulomegaly and proteinuria in a patient with idiopathic pulmonary hyptension. J Am Soc Nephrol ,1997,8:1 966
  • 7Reisin E, Harris KY,Azar S et al. A low-calorie unrestricted protein diet attenuates kidney damage in uninephrectomized spontaneously hypertensive rats. Am J Nephrol, 1999,19:433
  • 8Praga M, Hemandez E, Morales E et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant,2001, 16:1 790
  • 9Gades MD, van Goor H, Kaysen GA et al. Brief periods of hyperphagia cause renal injury in the obese Zucker rat. Kidney Int, 1999,56:1 779
  • 10Maddox DA, Alavi FK, Silbernick EM et al . Protective effects of a soy diet in preventing obesity-linked renal disease. Kidney Int, 2002,61:96

共引文献3312

同被引文献61

  • 1α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志,2005,21(7):421-424. 被引量:133
  • 2王庆文.肥胖相关性肾病的临床表现[J].肾脏病与透析肾移植杂志,2005,14(4):343-344. 被引量:13
  • 3谌贻璞.代谢综合征肾损害:已知与未知[J].中华肾脏病杂志,2006,22(7):381-382. 被引量:12
  • 4郭增玉,刘国华,李航.IgA肾病合并肥胖的临床病理分析[J].中国临床医生杂志,2007,35(7):39-41. 被引量:4
  • 5Francischetti EA. Genelhu VA. Obesity-hypertension:an ongoing pandemic. Int J Clin Pract,2007,61(2):269-280.
  • 6Nangaku M, Shankland SJ, Courser WG. Cellular response to injury in membranous nephropathy, J Am Soc Nephrol. 2005,16 : 1195-1024.
  • 7Hui-Mei Chen, Zhi-Hong Liu, Cai-Hong Zeng, et al. Podocyte lesions in patients with obesity-related glomeru-lopathy. American Journal of Kidney Diseases,2006,48 (5) :772-779.
  • 8Guo JK, Menke AL, Gubler MC, et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Human Molecular Genetics, 2002,11 ( 6 ) : 651 - 659.
  • 9Pavenstdt H, Kriz W, Kretzler M, et al. Cell biology of the glomerular podocyte. Physiol Rev ,2003,83 ( 1 ) :253-307.
  • 10Benigni A, Gagliardini E, Remuzzi G. Changes in glomerularperm-selectivity induced by angiotention Ⅱ imply podocyte dysfunction and slit diaphragm protein rearrangement. Semin Nephrol,2004,24 ( 2 ) : 131-140.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部